Trial Profile
A Prospective, Multicentre, Observational, Open-Label Study Investigating the Effectiveness and Safety of Ledipasvir plus Sofosbuvir in Adolescents with Chronic Hepatitis C Virus Genotype 4 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2020
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 12 Feb 2018 New trial record
- 19 Jan 2018 Results published in the Alimentary Pharmacology and Therapeutics Journal.